Becton Dickinson and Company Limited

Peter W Heyman

Paul G Alchas

Marina S Korisch

Carlos E Guillermo

Philippe Emile Fernand Laurent

John Laiosa

Lionel Vedrine

Todd M Chelak

Robert C West

Robert E West

Laurent Barrelle

Adriano Morigi

Steven Lau

Michael Goh

William Easterbrook

Philippe Emile Fernand

An intradermal injection device comprising a unitary body having an open distal end and a proximal end having a skin engaging surface defined thereon, a reservoir defined between the proximal and distal ends for accommodating a drug substance, and a channel defined at the proximal end of the unitary body and extending through, and distally from, the skin engaging surface to the reservoir. A needle cannula having a sharpened proximal end and a distal end may be provided in the channel. The needle cannula is secured in the channel with the distal end being in communication with the reservoir and the proximal end of the needle cannula extending from the skin engaging surface a distance in the range of about 0.5 mm to 3.0 mm such that the skin engaging surface limits penetration of the proximal end of the needle cannula to the dermis layer of the skin of a patient.

Intradermal injection device

A medication delivery device, particularly an intradermal delivery device, having a needle cannula, with a sharpened distal end having a forward tip, and a limiter disposed about the needle cannula. The limiter has a distal end defining a skin engaging surface which is disposed transversely to, and at least partially about, the needle cannula. The skin engaging surface is generally non-flat with generally coplanar portions, and a recess being defined in the skin engaging surface which defines a void in or adjacent to the coplanar portions into which portions of a patient's skin can be deformed into when the skin engaging surface is pressed against the patient's skin. The forward tip of the needle cannula is spaced apart from a plane defined by the coplanar portions a distance ranging from about 0.5 mm to 3.0 mm such that the skin engaging surface limits penetration of the forward tip of the needle cannula to the dermis layer of the patient's skin.

Intradermal delivery device with contoured skin engaging surface geometry

An intradermal delivery method for use in intradermally injecting substances into the skin of an animal includes a needle cannula supported by a hub portion that is attachable to a prefillable container. A limiter portion surrounds the needle cannula and extends away from the hub portion toward a forward tip of the needle cannula. The limiter portion includes a skin engaging surface extending in a plane generally perpendicular to an axis of the needle cannula. The skin engaging surface is received against skin of an animal to administer an intradermal injection. The forward tip extends beyond the skin engaging surface a distance that enables penetration of the needle cannula into the dermis layer of the skin of the animal enabling injection of the substance into the dermis layer of the animal. The device includes enclosure means that is moveable for concealing the needle cannula after the injection has been administered.

Prefillable intradermal delivery device

An intradermal needle comprising a needle cannula assembly having a limiter portion, a hub portion and a needle cannula, a protective cap having a forward and rearward cap to protect and shield a needle cannula prior to and after use, and means for engaging the needle cannula assembly and the rearward cap after use. The mated forward and rearward cap provide a sterile enclosure for the needle cannula assembly prior to use. Removing the rearward cap permits the needle cannula assembly to be coupled to a drug delivery device, while the forward cap removably shields the needle cannula. Removing the forward cap then exposes the needle cannula for use. After use, the distal end of the needle cannula assembly is placed into the rearward cap and lockingly engaged therewith.

Intradermal needle

An intradermal delivery device for use in intradermally injecting substances into the skin of an animal includes a needle cannula supported by a hub portion that is attachable to a prefillable container. A limiter portion surrounds the needle cannula and extends away from the hub portion toward a forward tip of the needle cannula. The limiter portion includes a skin engaging surface extending in a plane generally perpendicular to an axis of the needle cannula. The skin engaging surface is received against skin of an animal to administer an intradermal injection. The forward tip extends beyond the skin engaging surface a distance that enables penetration of the needle cannula into the dermis layer of the skin of the animal enabling injection of the substance into the dermis layer of the animal. The device includes enclosure means that is moveable for concealing the needle cannula after the injection has been administered.

A controlled-dose dispenser is useful to provide drops of liquid substances such as drugs, vaccines, ophthalmic solutions or other fluid solutions. The dispenser includes a body preferably made from two sheets of plastic material that are thermoformed in face-to-face relationship. A portion of the body is generally flat with a reservoir, which preferably is generally rounded, in a central portion. The reservoir is adapted to contain a chosen liquid substance. An outlet port is in fluid communication with the reservoir. An outlet nozzle is secured to the outlet port. A cap portion seals off the end of the outlet nozzle until a breakable or frangible connection is broken to remove the cap portion. Once the cap portion is removed, the liquid substance within the reservoir can be dispensed through the nozzle and the cap portion preferably cannot be replaced so that the dispenser is especially suited to be a single-use device.

Controlled-dose dispenser with integral nozzle and cap

Clear medical packaging

An assembly (20) of syringes (22) includes a first layer (32) enclosing the syringes. The first layer maintains the syringes in an orientation where some of the syringes have a first, larger end aligned with the second, smaller end of the remainder of the syringes. The first layer also protects the syringes from outside contaminants. A second layer (34) encloses the first layer and protects it from outside contaminants. The syringes and the first layer preferably are sterilized within the second layer 34.

Growing community of inventors

Florham Park, NJ, United States of America

Peter W Heyman